Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
HHS cancels mRNA vaccine development funded by BARDA
The decision affects 22 projects valued at around $500 million collectively, and no new mRNA projects will be started.
Darren Incorvaia
Aug 5, 2025 7:20pm
AstraZeneca drops lead TCR therapy from $200M Neogene buy
Jul 29, 2025 4:13am
BMS names AZ's Cristian Massacesi as new chief medical officer
Jul 25, 2025 9:26am
AstraZeneca's blockbuster contender hits phase 3 gMG goals
Jul 24, 2025 6:20am
Fierce Pharma
AZ reveals plan for huge site in Virginia, part of $50B US outlay
Jul 22, 2025 7:45am
AstraZeneca amyloidosis drug fails to reduce mortality in ph. 3
Jul 16, 2025 4:28am
